BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26700078)

  • 1. Role of prulifloxacin in the treatment of acute rhinosinusitis.
    Passali D; Crisanti A; Bellussi LM
    Infez Med; 2015 Dec; 23(4):301-6. PubMed ID: 26700078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prulifloxacin.
    Keam SJ; Perry CM
    Drugs; 2004; 64(19):2221-34; discussion 2235-6. PubMed ID: 15456336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
    Chen Y; Yang H; Lu G; Wu X; Huang W; Wu Y; Lv X; Wu G; Zhang G; Li Q; Sun Y
    Chemotherapy; 2012; 58(3):249-56. PubMed ID: 22890091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of orally administered prulifloxacin into human prostate tissue.
    Giberti C; Gallo F; Rosignoli MT; Ruggieri A; Barattè S; Picollo R; Dionisio P
    Clin Drug Investig; 2009; 29(1):27-34. PubMed ID: 19067472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prulifloxacin: a new antibacterial fluoroquinolone.
    Prats G; Rossi V; Salvatori E; Mirelis B
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):27-41. PubMed ID: 16441207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
    Giannarini G; Tascini C; Selli C
    Future Microbiol; 2009 Feb; 4(1):13-24. PubMed ID: 19207096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
    Cazzola M; Salvatori E; Dionisio P; Allegra L
    Pulm Pharmacol Ther; 2006; 19 Suppl 1():30-7. PubMed ID: 16359895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial therapy for chronic bacterial prostatitis.
    Perletti G; Marras E; Wagenlehner FM; Magri V
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections.
    Rafailidis PI; Polyzos KA; Sgouros K; Falagas ME
    Int J Antimicrob Agents; 2011 Apr; 37(4):283-90. PubMed ID: 21300527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.
    Carmignani G; De Rose AF; Olivieri L; Salvatori E; Rosignoli MT; Dionisio P
    Urol Int; 2005; 74(4):326-31. PubMed ID: 15897698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic characteristics of prulifloxacin.
    Matera MG
    Pulm Pharmacol Ther; 2006; 19 Suppl 1():20-9. PubMed ID: 16360331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of prulifloxacin into sinus mucosa of patients undergoing paranasal sinus elective endoscopic surgery.
    De Benedetto M; Passali D; Tomacelli G; Ruggieri A; Rosignoli MT; Picollo R; Bellussi L; Dionisio P
    J Chemother; 2012 Feb; 24(1):26-31. PubMed ID: 22546721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
    Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
    J Chemother; 2007 Jun; 19(3):304-8. PubMed ID: 17594926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
    Klossek JM
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.
    Blasi F; Aliberti S; Tarsia P; Santus P; Centanni S; Allegra L
    Int J Chron Obstruct Pulmon Dis; 2007; 2(1):27-31. PubMed ID: 18044063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.
    Rosignoli MT; Di Loreto G; Dionisio P
    Clin Drug Investig; 2010; 30(1):5-14. PubMed ID: 19995094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
    Pasqua F; Biscione G; Crigna G; Cazzola M
    Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
    Anon JB
    Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study.
    Cai T; Mazzoli S; Addonisio P; Boddi V; Geppetti P; Bartoletti R
    Methods Find Exp Clin Pharmacol; 2010; 32(1):39-45. PubMed ID: 20383345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.